Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical trials for treatment of respiratory viral infections in recipients of haematopoietic cell transplantation and cellular therapies: are we on the right path to the finish line?
Sassine J, Hirsch HH, Chemaly RF; European Society for Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV). Sassine J, et al. Clin Microbiol Infect. 2024 Mar;30(3):270-275. doi: 10.1016/j.cmi.2023.09.013. Epub 2023 Sep 22. Clin Microbiol Infect. 2024. PMID: 37742829 No abstract available.
Mortality in recipients of allogeneic haematopoietic cell transplantation in the era of cytomegalovirus primary prophylaxis: a single-centre retrospective experience.
Febres-Aldana A, Khawaja F, Morado-Aramburo O, Shigle TL, Rondon G, Sassine J, Spallone A, Srinivasan K, Ramdial J, Alousi A, Champlin R, Chen G, Daher M, Rezvani K, Ariza-Heredia EJ, Shpall EJ, Chemaly RF. Febres-Aldana A, et al. Among authors: sassine j. Clin Microbiol Infect. 2024 Jun;30(6):803-809. doi: 10.1016/j.cmi.2024.03.001. Epub 2024 Mar 8. Clin Microbiol Infect. 2024. PMID: 38460821
Cytomegaloviral Infections in Recipients of Chimeric Antigen Receptor T-Cell Therapy: An Observational Study With Focus on Oncologic Outcomes.
Khawaja F, Ahmed S, Iyer SP, Sassine J, Handley G, Prakash R, VanWierren T, Jackson J, Zubovskaia A, Ramdial J, Rondon G, Patel KK, Spallone A, Ariza-Heredia EJ, Mulanovich V, Angelidakis G, Jiang Y, Chemaly RF. Khawaja F, et al. Among authors: sassine j. Open Forum Infect Dis. 2024 Jul 18;11(8):ofae422. doi: 10.1093/ofid/ofae422. eCollection 2024 Aug. Open Forum Infect Dis. 2024. PMID: 39086466 Free PMC article.
Infections in immunocompromised hosts: progress made and challenges ahead.
Sassine J, Skevaki C, Chemaly RF; European Society for Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV). Sassine J, et al. Clin Microbiol Infect. 2025 Jan;31(1):22-23. doi: 10.1016/j.cmi.2024.10.017. Epub 2024 Oct 22. Clin Microbiol Infect. 2025. PMID: 39447745 No abstract available.
Disseminated histoplasmosis after alemtuzumab.
Siegrist EA, Thomas C, Khawandanah M, Sassine J. Siegrist EA, et al. Among authors: sassine j. Transpl Infect Dis. 2023 Dec;25(6):e14089. doi: 10.1111/tid.14089. Epub 2023 Jun 15. Transpl Infect Dis. 2023. PMID: 37323093 No abstract available.
32 results